Inventiva S.A.: Sale of Shares
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA.
DAIX, France, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Further to the earlier announcement on 23 August 2018, Frédéric Cren and Pierre Broqua (together, the "Co-founders") and Jean Volatier (collectively, the "Sellers"), respectively the Chief Executive Officer, Chief Scientific Officer and Chief Financial Officer of Inventiva S.A. (the "Company" or "Inventiva"), announce that they have sold in aggregate 255,000 existing shares in Inventiva, equivalent to up to approximately 1.15% of the existing share capital and 1.56% of the voting rights of the Company (the "Transaction"). Jefferies International Limited (the "Manager") managed the Transaction.
Following settlement of the Transaction, the Co-founders will remain the main shareholders of the Company with Frédéric Cren and Pierre Broqua still holding (i) acting in concert, 43.91% of Inventiva's share capital and 60.53% of the voting rights and (ii) individually, 26.46% and 17.44% of Inventiva's share capital and 36.48% and 24.05% of the voting rights, respectively. In relation to the Transaction, the Sellers have agreed to make no further additional sales of shares in Inventiva for a period of 90 days (the "Lock-up Period") without prior consent from the Manager. The Lock-up Period excludes shares relating to the call option agreements entered into with BVF Partners L.P. and Perceptive Advisors by which Frédéric Cren and Pierre Broqua agreed to grant a call option on existing shares in the context of the initial public offering of the Company.
Inventiva will not receive any proceeds from the Transaction.
THIS ANNOUNCEMENT IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE INTO THE UNITED STATES. THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES, EXCEPT PURSUANT TO AN APPLICABLE EXEMPTION FROM REGISTRATION. NO PUBLIC OFFERING OF SECURITIES IS BEING MADE IN THE UNITED STATES.
THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES OR INVESTMENTS FOR SALE OR A SOLICITATION OF AN OFFER TO BUY SECURITIES OR INVESTMENTS IN ANY JURISDICTION WHERE SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL. NO ACTION HAS BEEN TAKEN THAT WOULD PERMIT AN OFFERING OF THE SECURITIES OR POSSESSION OR DISTRIBUTION OF THIS ANNOUNCEMENT IN ANY JURISDICTION WHERE ACTION FOR THAT PURPOSE IS REQUIRED. PERSONS INTO WHOSE POSSESSION
THIS ANNOUNCEMENT COMES ARE REQUIRED TO INFORM THEMSELVES ABOUT AND TO OBSERVE ANY SUCH RESTRICTIONS. ANY FAILURE TO COMPLY WITH THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF ANY SUCH JURISDICTION.
THE OFFER AND SALE OF THE INVENTIVA SHARES BY THE SELLERS IN FRANCE WILL BE CARRIED OUT THROUGH A PRIVATE PLACEMENT TO QUALIFIED INVESTORS, IN ACCORDANCE WITH ARTICLE L.411-2 OF THE FRENCH FINANCIAL AND MONETARY CODE AND OTHER APPLICABLE LAWS AND REGULATIONS. THERE WILL BE NO PUBLIC OFFERING IN FRANCE.
IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA ("EEA") WHICH HAVE IMPLEMENTED THE PROSPECTUS DIRECTIVE (EACH, A "RELEVANT MEMBER STATE"), THIS ANNOUNCEMENT AND ANY OFFER IF MADE SUBSEQUENTLY IS DIRECTED EXCLUSIVELY AT PERSONS WHO ARE "QUALIFIED INVESTORS" WITHIN THE MEANING OF THE PROSPECTUS DIRECTIVE ("QUALIFIED INVESTORS"). FOR THESE PURPOSES, THE EXPRESSION "PROSPECTUS DIRECTIVE" MEANS DIRECTIVE 2003/71/EC (AND AMENDMENTS THERETO, INCLUDING THE 2010 PD AMENDING DIRECTIVE, TO THE EXTENT IMPLEMENTED IN A RELEVANT MEMBER STATE), AND INCLUDES ANY RELEVANT IMPLEMENTING MEASURE IN THE RELEVANT MEMBER STATE AND THE EXPRESSION "2010 PD AMENDING DIRECTIVE" MEANS DIRECTIVE 2010/73/EU.
WITH RESPECT TO THE RELEVANT MEMBER STATES, OTHER THAN FRANCE, NO ACTION HAS BEEN OR WILL BE TAKEN IN ORDER TO PERMIT A PUBLIC OFFER OF THE SECURITIES WHICH WOULD REQUIRE THE PUBLICATION OF A PROSPECTUS IN ANY RELEVANT MEMBER STATES.
THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OR A SOLICITATION TO SELL OR SUBSCRIBE REQUIRING A PROSPECTUS WITHIN THE MEANING OF THE PROSPECTUS DIRECTIVE. THIS ANNOUNCEMENT DOES NOT, AND SHALL NOT, IN ANY CIRCUMSTANCES CONSTITUTE A PUBLIC OFFERING, NOR AN OFFER TO SELL OR SUBSCRIBE, NOR A SOLICITATION TO OFFER TO PURCHASE OR SUBSCRIBE SECURITIES IN ANY JURISDICTION.
IN THE UNITED KINGDOM THIS ANNOUNCEMENT IS DIRECTED EXCLUSIVELY AT QUALIFIED INVESTORS (I) WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS FALLING WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE "ORDER") OR (II) WHO FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER, AND (III) TO WHOM IT MAY OTHERWISE LAWFULLY BE COMMUNICATED.
IN CONNECTION WITH THE TRANSACTION, THE MANAGER AND ANY OF ITS AFFILIATES ACTING AS AN INVESTOR FOR THEIR OWN ACCOUNT MAY TAKE UP AS A PRINCIPAL POSITION ANY SHARES AND IN THAT CAPACITY MAY RETAIN, PURCHASE OR SELL FOR THEIR OWN ACCOUNT SUCH SHARES. IN ADDITION THE MANAGER OR ITS AFFILIATES MAY ENTER INTO FINANCING ARRANGEMENTS AND SWAPS WITH INVESTORS IN CONNECTION WITH WHICH THE MANAGER (OR ITS AFFILIATES) MAY FROM TIME TO TIME ACQUIRE, HOLD OR DISPOSE OF SHARES. THE MANAGER DO NOT INTEND TO DISCLOSE THE EXTENT OF ANY SUCH INVESTMENT OR TRANSACTIONS OTHERWISE THAN IN ACCORDANCE WITH ANY LEGAL OR REGULATORY OBLIGATION TO DO SO.
NO GUARANTEE CAN BE MADE THAT ANY SECURITIES WILL BE SOLD PURSUANT TO THE TRANSACTION.
THE MANAGER IS ACTING ON BEHALF OF THE SELLERS AND NO ONE ELSE IN CONNECTION WITH THE TRANSACTION AND WILL NOT BE RESPONSIBLE TO ANY OTHER PERSON FOR PROVIDING THE PROTECTIONS AFFORDED TO CLIENTS OF THE MANAGER OR FOR PROVIDING ADVICE IN RELATION TO THE TRANSACTION.
This press release was submitted for publication on 23 August 2018 at 17:30 (CEST).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
ILPA Publishes Diversity and Inclusion Resources for the Private Equity Industry24.9.2018 13:00 | Pressemelding
Expansion to the ILPA Standard DDQ and Guidance on Code of Conduct Seek to Advance D&I Efforts Across the Ecosystem WASHINGTON and TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- The Institutional Limited Partners Association (ILPA) today announced the publication of several resources developed to support the advancement of diversity and inclusion (D&I) within the private equity (PE) industry. These resources include an expansion to ILPA’s standard Due Diligence Questionnaire (DDQ) and guidance for developing organizational Codes of Conduct for general partners (GPs), limited partners (LPs) and fund portfolio companies. The work was completed over the course of 2018 by a cross section of ILPA members representing a global perspective. Steve Nelson, CEO of ILPA, reflected on the imperative for all industry players to contribute to the D&I effort in a positive manner: “ILPA believes that diversity and inclusion is a strength that all stakeholders within the private equity ecosystem should em
SolarWinds to Showcase Change Monitoring and Extended Azure Monitoring Capabilities Across Unified Infrastructure Management and SaaS solutions Portfolio at Microsoft Ignite 201824.9.2018 12:30 | Pressemelding
Highlights support for IT Professionals and DevOps teams operating on and across Microsoft on-premise environments, Microsoft Azure, and Office 365 AUSTIN, Texas, Sept. 24, 2018 (GLOBE NEWSWIRE) -- SolarWinds, a leading provider of powerful and affordable IT management software, today announced its participation at Microsoft Ignite® 2018, September 24-28, 2018, in Orlando, Florida. SolarWinds will demonstrate the latest updates to its unified infrastructure management portfolio, built on the SolarWinds® Orion® Platform, alongside its suite of SaaS-delivered products designed for DevOps teams. These portfolio enhancements are designed to deepen visibility across both cloud infrastructure and applications to simplify full-stack monitoring for DevOps and IT professionals. The company will also preview its upcoming Cost Calculator for Microsoft® Azure® free tool. “Optimizing performance across even the most complex environments can be accomplished,” said Christoph Pfister, executive vice p
Barefoot Networks Teams Up with Western Digital and Università della Svizzera italiana to Showcase In-Network Consensus for Use with Storage Class Memory and P424.9.2018 09:00 | Pressemelding
Barefoot Tofino™ Used in P4 Implementation for Low Latency Storage Class Memory Access is Presented at the P4 European Workshop CAMBRIDGE, United Kingdom, Sept. 24, 2018 (GLOBE NEWSWIRE) -- P4 European Workshop —At the P4 European Workshop (P4EU 2018), Barefoot Networks and researchers from Western Digital and Università della Svizzera italiana (USI), with support from Xilinx and STORDIS, will today present a new breakthrough for providing in-network high-performance fault tolerance for Storage Class Memory (SCM) access using the P4 programming language. The demonstration uses a P4 program implementation developed by Western Digital and USI using Barefoot’s 6.5Tb/s Tofino™ switch ASIC. Programmable forwarding plane technology is enabling network owners to create and deliver value by accelerating application performance. One of the ways this is achieved is by offloading network functions that are run on servers or appliances onto switches. In addition to performing all standard switch a
4D Announces Positive Data From Phase 1b Study of Thetanix in Paediatric Crohn's Diseases Patients and Publication of Studies Showing Strong Efficacy of Thetanix in Preclinical Models of IBD24.9.2018 08:00 | Pressemelding
LEEDS, United Kingdom, Sept. 24, 2018 (GLOBE NEWSWIRE) -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announces positive top-line results for its Phase 1b study of Thetanix in paediatric patients with Crohn’s disease. The study achieved its primary objective, demonstrating that Thetanix was well tolerated with a good safety profile. The randomised, double-blind, placebo-controlled study was conducted in two parts, with a single-dose phase and a multiple-dose phase and treated a total of 18 subjects aged 16-18 with Crohn’s disease. In the single-dose phase, eight subjects were given a single dose of either Thetanix or placebo. In the multiple-dose phase, 10 subjects were given either Thetanix or placebo twice daily for seven consecutive days. The Company also announces the publication of data demonstrating the efficacy of Thetanix in pre-clinical models of inflammatory bowel disease (IBD). The data, published in the journal
Researchers, Survivors, Advocates and Physicians Convene to Discuss Innovations in Lung Cancer Research, Treatment and Advocacy at the Largest-Attended World Conference on Lung Cancer24.9.2018 01:00 | Pressemelding
TORONTO, Sept. 23, 2018 (GLOBE NEWSWIRE) -- Patients, survivors and advocates joined researchers and physicians from across the globe to discuss the future of lung cancer at the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada. The conference’s first press briefing highlighted the record-breaking number of registered attendees (over 7,300), reviewed patient-caregiver communities working to accelerate research, evaluated survey data on the emotional needs of lung cancer survivors and underscored the impact of comprehensive genomic profiling on patient care. The press conference opened with a welcome message from conference co-presidents Natasha B. Leighl, M.D., BSc, MSc; Andrea Bezjak, M.D., FRCPC, MSc; and Gail Darling M.D., FRCSC, who have worked tirelessly to make this year’s conference in Toronto highly successful. Oncogene-driven patient-caregiver communities creating new paradigm for non-small cell lu
Bombardier Delivers First 90-seat Q400 Aircraft to SpiceJet21.9.2018 16:00 | Pressemelding
SpiceJet becomes the first airline to take advantage of the Q400 aircraft’s increased profit potential TORONTO, Sept. 21, 2018 (GLOBE NEWSWIRE) -- Bombardier Commercial Aircraft today announced the delivery of its first 90-seat Q400 aircraft. The aircraft was handed over to India’s SpiceJet Limited (“SpiceJet”) the launch operator for the extra-capacity, 90-seat aircraft. “We are excited to induct the 90-seat Q400 aircraft into our fleet,” said Ajay Singh, Chairman and Managing Director, SpiceJet. “The additional seats and performance improvements will result in substantial reduction in unit costs and also we will enable us to address our market needs in the regional space.” “The delivery of the first 90-seat Q400 aircraft showcases the commitment of Bombardier’s Q Series turboprop program to respond to customer requirements as they address traffic growth in regional markets,” said Todd Young, Head of the Q Series Aircraft Program, Bombardier Commercial Aircraft. “I thank and congratul
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom